Let’s Talk Ophthalmology: an Evolve Medical Education Podcast

The pipeline for the treatment of wet age-related macular degeneration includes therapies that focus on new molecular targets. Carl J. Danzig, MD, FASRS, discusses a tyrosine kinase inhibitor.

This activity is supported by an independent medical education grant from Ocular Therapeutix.

Click here to view the webinar event, which includes images from the talk.

Want to view more education? Click here.

David Eichenbaum, MD, will discuss the bioresorbable, hydrogel axitinib intravitreal implant that is under investigation in the SOL-1 phase 3 trial for the treatment of neovascular age-related macular degeneration.

This activity is supported by an independent medical education grant from Ocular Therapeutix.

Click here to view the webinar event, which includes images from the talk.

Want to register with Evolve Medical Education? Click here.

Margaret A. Chang, MD, MS, will discuss gene therapies in the pipeline for the treatment of neovascular age-related macular degeneration.

This activity is supported by an independent medical education grant from Ocular Therapeutix.

Click here to view the webinar event, which includes images from the talk.

Want to register with Evolve Medical Education? Click here.

Drs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the interpretation of clinical trial data and the subsequent integration of these therapies into clinical practice.

This activity is supported by an independent medical education grant from Ocular Therapeutix.

Click here to view the webinar event, which includes images from the talk.

Want to register with Evolve Medical Education? Click here.

Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, highlight best practices when treating neurotrophic keratitis, including differential diagnosis, corneal sensitivity testing, the new classification system, treatments options for each stage, and pipeline therapies.

This activity is supported by an unrestricted educational grant from Dompé.

Click here to view the webinar event, which includes images from the talk.  

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Drs. Donaldson and Starr delve into cenegermin’s clinical trial data and whether or not it should be used in patients with stage 1 neurotrophic keratitis (NK). They also discuss a handful of investigational agents for treating NK.

This activity is supported by an unrestricted educational grant from Dompé.

Click here to view the webinar event, which includes images from the talk.  

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Kendall E. Donaldson, MD, MS and Christopher E. Starr, MD, discuss why it’s important to treat stage 1 neurotrophic keratitis, the treatment options for each stage, and a patient who was treated with multiple therapies.

This activity is supported by an unrestricted educational grant from Dompé.

Click here to view the webinar event, which includes images from the talk.  

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

In this case-based discussion focused on diabetic macular edema, Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, highlight the use of more durable treatment options and how to incorporate these second-generation therapies into the armamentarium.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Click here to view the webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Murtaza Adam, MD, FASRS, and Lejla Vajzovic, MD, FASRS, discuss two cases involving patients with neovascular age-related macular degeneration and the decision-making process used to determine the best treatment approaches.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Click here to view the webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.

Back by popular demand, this fun and exciting game show-style program features key opinion leaders (KOLs) as contestants!

Hosted by Dr. Blake K. Williamson, this episode is full of learning and laughter! The winner of Round 2, Dr. Sumitra Khandelwal, joins two new KOLs, Drs. Kendall E. Donaldson & Vance Thompson, to battle it out in this final round!

Who is the champion? Listen now to find out!

This activity is supported by an independent educational grant from Alcon.

Click here to view the webinar event, which includes images from the talk.

Check out the central hub of this webinar series.

Want to register with Evolve Medical Education? Click here.